Cryogen spray cooling mitigates inflammation and injury-induced CISD2 decline in rat spinal cord hemisection model

J Integr Neurosci. 2020 Dec 30;19(4):619-628. doi: 10.31083/j.jin.2020.04.255.

Abstract

Therapeutic strategies for traumatic spinal cord injury generally involve rectifying concomitant destruction to the spinal cord from inflammation, mitochondrial dysfunction, and eventual neuronal apoptosis. Elevating the expression of spinal cord injury-attenuated CDGSH iron-sulfur domain-2 has been shown to mitigate the pathologies above. In the current work, hypothermia was induced via continuous cryogen spray cooling in a rat spinal cord hemisection model. Spinal cord injury was shown to elevate the mRNA expression of proinflammatory mediators, including NFκB, iNOS, TNF-α, and regulated upon activation, normal T-cell expressed and secreted as well as lower CDGSH iron-sulfur domain-2 expression. Cryogen spray cooling treatment was shown to attenuate inflammatory reactions and elevate CDGSH iron-sulfur domain-2 expression. Immunohistochemical analysis of the glial fibrillary acidic protein, caspase-3 and NeuN in spinal cord injured rats that underwent cryogen spray cooling treatment revealed notable reductions in injury-induced astrocytic activation, apoptosis, neuronal loss, and decline in CDGSH iron-sulfur domain-2 expression. These results demonstrate the CDGSH iron-sulfur domain-2 preserving effects of cryogen spray cooling, which could contribute to the prevention of astrocytic activation, astrocyte-mediated neuroinflammation, apoptosis, and neuron loss.

Keywords: CISD2; Cryogen spray cooling; apoptosis; astrocyte activation; hypothermia; inflammatory response; neuronal loss; spinal cord injury.

MeSH terms

  • Animals
  • Apoptosis* / physiology
  • Astrocytes* / immunology
  • Astrocytes* / metabolism
  • Astrocytes* / pathology
  • Disease Models, Animal
  • Hypothermia / chemically induced*
  • Hypothermia, Induced*
  • Inflammation* / etiology
  • Inflammation* / metabolism
  • Inflammation* / pathology
  • Inflammation* / therapy
  • Male
  • Membrane Proteins / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Cord Injuries* / complications
  • Spinal Cord Injuries* / metabolism
  • Spinal Cord Injuries* / pathology
  • Spinal Cord Injuries* / therapy

Substances

  • CISD2 protein, human
  • Membrane Proteins